查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1968516

3D列印醫療設備市場－全球產業規模、佔有率、趨勢、機會、預測：按組件、應用、地區和競爭對手分類，2021-2031年

3D Printing Medical Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球 3D 列印醫療設備市場預計將從 2025 年的 27.7 億美元成長到 2031 年的 46.3 億美元，複合年成長率為 8.94%。

該行業專注於利用積層製造技術，根據數位化設計生產患者特異性的解剖模型、手術器械、植入和義肢。其主要成長要素包括：為提高手術精準度和病患復原效果，​​人們對個人化醫療的需求日益成長；以及需要複雜介入的慢性疾病盛行率不斷上升。這些因素推動了積層製造技術的應用，以改善術前規劃並縮短手術時間。

市場概覽
預測期 2027-2031
市場規模：2025年 27.7億美元
市場規模：2031年 46.3億美元
複合年成長率：2026-2031年 8.94%
成長最快的細分市場 植入
最大的市場 北美洲

然而，嚴格的監管要求和生物相容性材料的高成本等因素構成了市場准入的重大障礙，可能導致產品核可和市場准入的延遲。滿足複雜的安全標準至關重要，但這需要製造商投入大量資源。 2024年，北美放射學會（RSNA）宣布，RSNA-ACR 3D列印註冊庫已記錄了2,637例臨床病例，其中包括1,863個解剖模型和774個用於患者照護的解剖導板。

市場促進因素

隨著醫療機構致力於提高手術精準度和改善病患預後，對個人化、病患特異性醫療設備的需求激增，成為推動產業發展的主要動力。客製化的解剖模型和手術導板能夠實現精細的術前規劃，並顯著降低術中風險和縮短手術時間。這一趨勢也得益於主要市場參與者的強勁財務表現；例如，3D Systems公司在2024年11月公佈其個人化醫療業務年增約20%，顯示個體化醫療解決方案正被迅速採用。

同時，由於積層製造技術在牙科、整形外科和義肢的應用日益廣泛，市場規模也不斷擴大，透明矯正器和其他類似產品的大量生產已成為標準流程。牙科領域利用積層製造技術生產數百萬副客製化矯正器，充分展現了該技術的擴充性。 2024年1月，Align Technology宣布其透明矯正器的年銷售額達到32億美元，凸顯了3D列印牙科產品的龐大商業規模。此外，2024年2月，Materialise報告稱，其2023會計年度醫療保健銷售額年增19.5%，超過1.01億歐元，反映了該市場的整體韌性。

市場挑戰

全球3D列印醫療設備市場正面臨嚴格法規結構的巨大挑戰，該框架規範著積層製造產品的核准和商業化。製造商必須在複雜的合規環境下運營，該環境要求提供大量的臨床證據和嚴格的品管體系，以確保患者安全。這些監管障礙往往導致測試和檢驗週期延長，增加了將針對特定患者的解決方案推向市場所需的資金和時間，同時迫使企業將大量研發資源轉移到滿足合規標準。

這些監管障礙的具體影響在近期行業對認證時間表的評估中顯而易見。根據2024年歐洲醫療技術展（MedTech Europe）的一項調查，50%的醫療設備製造商表示，由於新法規下的性能和臨床評估問題，至少有一項認證申請被大幅延遲或駁回。這些延誤不僅擾亂了供應鏈，也造成了財務不穩定，抑制了對新型3D列印技術的投資，並限制了整個市場的成長潛力。

市場趨勢

生物列印技術在組織工程領域的進步正在重塑該領域，它能夠製造出超越傳統非生物材料替代品的生物整合再生植入。這項技術突破使得利用3D列印技術建構生物組織支架和生物可吸收裝置成為可能，從而恢復人體自然生理功能，這對於軟組織修復和複雜神經再生尤為重要。 2025年6月，3D Systems公司宣布，其生物列印技術已獲得FDA的De Novo醫療設備認證，用於開發一種專有的、用於周圍神經修復的生物可吸收裝置，這充分展現了再生醫學製造的商業性潛力。

同時，人工智慧 (AI) 與器械設計的融合正在革新患者特異性整形外科和肌肉植入的製造方式。透過利用機器學習演算法，製造商可以自動將醫學影像資料轉換為精確的數位藍圖，從而顯著縮短設計時間。人工智慧與積層製造的結合，使得建構複雜的晶格結構成為可能，進而改善骨整合和機械性能。為了佐證這一趨勢，醫療器材網路 (Medical Device Network) 在 2025 年 4 月報道稱，restor3d 已獲得 3,800 萬美元的資金籌措，用於加速其利用專有人工智慧規劃原理開發的四條全新植入產品線的商業化進程。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球3D列印醫療設備市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依組件分類（3D列印機、3D生物列印機、材料、軟體、服務）
    • 依應用領域（手術導板、義肢、植入）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美3D列印醫療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲3D列印醫療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區3D列印醫療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲3D列印醫療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲3D列印醫療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球3D列印醫療設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • 3D Systems, Inc.
  • 3T Additive Manufacturing Ltd
  • Carbon, Inc
  • Cyfuse Biomedical KK
  • EnvisionTEC
  • EOS GmbH Electro Optical Systems
  • FabRx Ltd
  • Prodways Group
  • Renishaw plc
  • Stratasys Ltd

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 20026

The Global 3D Printing Medical Devices Market is projected to expand from USD 2.77 Billion in 2025 to USD 4.63 Billion by 2031, reflecting a CAGR of 8.94%. This industry focuses on using additive manufacturing to create patient-specific anatomical models, surgical tools, implants, and prosthetics derived from digital designs. Key growth factors include the increasing demand for personalized medicine to enhance surgical precision and patient recovery, as well as the rising prevalence of chronic conditions that require complex interventions, thereby driving the adoption of these technologies for better pre-operative planning and shorter procedure times.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.77 Billion
Market Size 2031USD 4.63 Billion
CAGR 2026-20318.94%
Fastest Growing SegmentImplants
Largest MarketNorth America

However, the market confronts substantial obstacles due to strict regulatory requirements and the high cost of biocompatible materials, which can slow down product approval and market entry. Meeting complex safety standards is mandatory but demands significant resources from manufacturers. In 2024, the Radiological Society of North America noted that the RSNA-ACR 3D Printing Registry recorded a cumulative total of 2,637 clinical cases, consisting of 1,863 anatomic models and 774 anatomic guides used for patient care.

Market Driver

The surging demand for personalized and patient-specific medical devices acts as a major catalyst for the industry, as healthcare providers strive to enhance surgical accuracy and patient outcomes. Custom anatomical models and surgical guides facilitate detailed pre-operative planning, which significantly lowers intraoperative risks and procedure duration. This trend is supported by the strong financial results of key market players; for instance, 3D Systems reported in November 2024 that its Personalized Healthcare segment grew by nearly 20% compared to the previous year, indicating a rapid uptake of tailored medical solutions.

Simultaneously, the market's scope is widening through expanded applications in dentistry, orthopedics, and prosthetics, where high-volume production of items like clear aligners has become a standard practice. The dental sector's use of additive manufacturing to produce millions of custom aligners highlights the technology's scalability. Align Technology reported full-year Clear Aligner revenues of $3.2 billion in January 2024, demonstrating the immense commercial scale of 3D-printed dental products. Additionally, Materialise reported in February 2024 that its Medical segment revenue increased by 19.5% year-over-year to over €101 million for fiscal year 2023, reflecting broader market resilience.

Market Challenge

The Global 3D Printing Medical Devices Market faces significant headwinds arising from rigid regulatory frameworks that control the approval and commercialization of additive manufacturing products. Manufacturers must operate within complex compliance environments that require extensive clinical evidence and strict quality management systems to guarantee patient safety. These regulatory hurdles often lead to extended testing and validation periods, increasing the capital and time needed to bring patient-specific solutions to market while forcing companies to divert essential resources from research and development to meet compliance standards.

The tangible impact of these regulatory barriers is highlighted in recent industry assessments regarding certification timelines. According to MedTech Europe in 2024, 50% of medical device manufacturers reported that at least one certificate application was significantly delayed or resulted in a negative outcome due to issues with performance or clinical evaluation under new regulations. Such delays not only interrupt supply chains but also create financial instability, discouraging investment in new 3D printing technologies and limiting the overall expansion potential of the market.

Market Trends

Advancements in bioprinting for tissue engineering are reshaping the sector by allowing the creation of bio-integrative and regenerative implants that surpass traditional inert replacements. This technological leap utilizes 3D printing to build living tissue scaffolds and bioabsorbable devices capable of restoring natural physiological functions, which is particularly vital for soft tissue repair and complex nerve regeneration. In June 2025, 3D Systems announced that its bioprinting technologies facilitated FDA De Novo marketing authorization for a unique bioabsorbable device designed for peripheral nerve repair, validating the commercial potential of regenerative manufacturing.

Concurrently, the integration of artificial intelligence into device design is revolutionizing the production of patient-specific orthopedic and musculoskeletal implants. By utilizing machine learning algorithms, manufacturers can automate the translation of medical imaging data into precise digital blueprints, drastically reducing engineering time. This combination of AI and additive manufacturing enables the creation of complex lattice structures that improve osseointegration and mechanical performance. Highlighting this trend, Medical Device Network reported in April 2025 that restor3d secured $38 million in financing to accelerate the commercialization of four new implant product lines developed using proprietary AI-based planning principles.

Key Market Players

  • 3D Systems, Inc.
  • 3T Additive Manufacturing Ltd
  • Carbon, Inc
  • Cyfuse Biomedical K.K
  • EnvisionTEC
  • EOS GmbH Electro Optical Systems
  • FabRx Ltd
  • Prodways Group
  • Renishaw plc
  • Stratasys Ltd

Report Scope

In this report, the Global 3D Printing Medical Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

3D Printing Medical Devices Market, By Component

  • 3 D Printer
  • 3 D Bioprinter
  • Material
  • Software
  • Services

3D Printing Medical Devices Market, By Application

  • Surgical Guides
  • Prosthetics
  • Implants

3D Printing Medical Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global 3D Printing Medical Devices Market.

Available Customizations:

Global 3D Printing Medical Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global 3D Printing Medical Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Component (3 D Printer, 3 D Bioprinter, Material, Software, Services)
    • 5.2.2. By Application (Surgical Guides, Prosthetics, Implants)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America 3D Printing Medical Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States 3D Printing Medical Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Component
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada 3D Printing Medical Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Component
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico 3D Printing Medical Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Component
        • 6.3.3.2.2. By Application

7. Europe 3D Printing Medical Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany 3D Printing Medical Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Application
    • 7.3.2. France 3D Printing Medical Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom 3D Printing Medical Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy 3D Printing Medical Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Component
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain 3D Printing Medical Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Component
        • 7.3.5.2.2. By Application

8. Asia Pacific 3D Printing Medical Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China 3D Printing Medical Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Application
    • 8.3.2. India 3D Printing Medical Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan 3D Printing Medical Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea 3D Printing Medical Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia 3D Printing Medical Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Application

9. Middle East & Africa 3D Printing Medical Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia 3D Printing Medical Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE 3D Printing Medical Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa 3D Printing Medical Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Application

10. South America 3D Printing Medical Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil 3D Printing Medical Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia 3D Printing Medical Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina 3D Printing Medical Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global 3D Printing Medical Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. 3D Systems, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. 3T Additive Manufacturing Ltd
  • 15.3. Carbon, Inc
  • 15.4. Cyfuse Biomedical K.K
  • 15.5. EnvisionTEC
  • 15.6. EOS GmbH Electro Optical Systems
  • 15.7. FabRx Ltd
  • 15.8. Prodways Group
  • 15.9. Renishaw plc
  • 15.10. Stratasys Ltd

16. Strategic Recommendations

17. About Us & Disclaimer